Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine Karis

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Southern Medical Journal|June 18, 2014
Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way streetElaine Karis, Daria B Crittenden, Michael H Pillinger
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
ReplyJeffrey R Curtis, Elaine Karis, Priscilla K Yen, et al.
Pharmacoepidemiology and Drug Safety|September 21, 2022
Examining the potential direct cardiovascular benefit of tumor-necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analysesKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.
ACR Open Rheumatology|April 11, 2022
Time-Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular RiskKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.
Lupus Science & Medicine|December 24, 2024
Real-world treatment patterns, healthcare resource utilisation and costs in patients with SLE in the USAPrajakta P Masurkar, Jennifer Reckleff, Nicole Princic, et al.
Lupus Science & Medicine|July 25, 2023
Improving resource utilisation in SLE drug development through innovative trial designSandra Garces, Elaine Karis, Joan T Merrill, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2020
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained RemissionJeffrey R Curtis, Paul Emery, Elaine Karis, et al.
The American Journal of Managed Care|July 27, 2021
Association of physician specialty with psoriatic arthritis treatment and costsErvant J Maksabedian Hernandez, Joseph Tkacz, Nicole M Zimmerman, et al.
ACR Open Rheumatology|September 29, 2020
Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona RegistryDimitrios A Pappas, Ying Shan, Tamara Lesperance, et al.
Rheumatology International|September 3, 2020
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry dataDimitrios A Pappas, Heather J Litman, Tamara Lesperance, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Southern Medical Journal|June 18, 2014
Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way streetElaine Karis, Daria B Crittenden, Michael H Pillinger
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
ReplyJeffrey R Curtis, Elaine Karis, Priscilla K Yen, et al.
Pharmacoepidemiology and Drug Safety|September 21, 2022
Examining the potential direct cardiovascular benefit of tumor-necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analysesKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.
ACR Open Rheumatology|April 11, 2022
Time-Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular RiskKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.
Lupus Science & Medicine|December 24, 2024
Real-world treatment patterns, healthcare resource utilisation and costs in patients with SLE in the USAPrajakta P Masurkar, Jennifer Reckleff, Nicole Princic, et al.
Lupus Science & Medicine|July 25, 2023
Improving resource utilisation in SLE drug development through innovative trial designSandra Garces, Elaine Karis, Joan T Merrill, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 18, 2020
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained RemissionJeffrey R Curtis, Paul Emery, Elaine Karis, et al.
The American Journal of Managed Care|July 27, 2021
Association of physician specialty with psoriatic arthritis treatment and costsErvant J Maksabedian Hernandez, Joseph Tkacz, Nicole M Zimmerman, et al.
ACR Open Rheumatology|September 29, 2020
Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona RegistryDimitrios A Pappas, Ying Shan, Tamara Lesperance, et al.
Rheumatology International|September 3, 2020
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry dataDimitrios A Pappas, Heather J Litman, Tamara Lesperance, et al.
Pageof 2